Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
Sanofi-aventis to acquire Oforta, oral chronic lymphocytic leukemia treatment

Sanofi-aventis to acquire Oforta, oral chronic lymphocytic leukemia treatment

Chronic lymphocytic leukemia linked to seven different gene variants

Chronic lymphocytic leukemia linked to seven different gene variants

New biomarker may predict aggressiveness of chronic lymphocytic leukemia

New biomarker may predict aggressiveness of chronic lymphocytic leukemia

Monoclonal antibody cancer therapy

Monoclonal antibody cancer therapy

FDA provides positive review of InNexus Biotechnology development plan for lead preclinical candidate

FDA provides positive review of InNexus Biotechnology development plan for lead preclinical candidate

FDA provides positive review of InNexus' lead preclinical drug candidate

FDA provides positive review of InNexus' lead preclinical drug candidate

B-cell clones as early markers for chronic lymphocytic leukemia

B-cell clones as early markers for chronic lymphocytic leukemia

Ingredient in cough medicine could treat prostate cancer

Ingredient in cough medicine could treat prostate cancer

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Networks of interactive genes may predict Leukemia's development

Networks of interactive genes may predict Leukemia's development

New chemotherapy pill shows promise for stubborn lymphomas

New chemotherapy pill shows promise for stubborn lymphomas

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients

Dismissed leukemia drug flavopiridol helps chronic lymphocytic leukemia patients

Discovery of novel drug target for chronic lymphocytic leukemia

Discovery of novel drug target for chronic lymphocytic leukemia

NCI sponsors Canadian cold/flu remedy trial in leukemia patients

NCI sponsors Canadian cold/flu remedy trial in leukemia patients

COLD-FX remedy undergoes NCI-sponsored trial in leukemia patients

COLD-FX remedy undergoes NCI-sponsored trial in leukemia patients

Novel leukemia therapy shows promise for high-risk patients

Novel leukemia therapy shows promise for high-risk patients

Genmab announces four studies of ofatumumab in chronic lymphocytic leukemia

Genmab announces four studies of ofatumumab in chronic lymphocytic leukemia

Researchers find way to make tumor cells more sensitive to hyperthermia-enhanced radiation therapy

Researchers find way to make tumor cells more sensitive to hyperthermia-enhanced radiation therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.